GENRX RIZATRIPTAN rizatriptan (as benzoate) 10 mg orally disintegrating tablets blister pack

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)

Dostępny od:

Arrotex Pharmaceuticals Pty Ltd

INN (International Nazwa):

rizatriptan benzoate

Forma farmaceutyczna:

Tablet, orally disintegrating

Skład:

Excipient Ingredients: crospovidone; sucralose; microcrystalline cellulose; mannitol; magnesium stearate; Flavour

Droga podania:

Oral

Sztuk w opakowaniu:

2

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

Rizatriptan is indicated for the acute treatment of migraine attacks with or without aura.

Podsumowanie produktu:

Visual Identification: White to off-white coloured, round-shaped tablets with "APO" engraved on one side and "RZ" over "10" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Status autoryzacji:

Licence status A

Data autoryzacji:

2016-02-09